Skip to main content
. 2018 May 16;68(1):113–119. doi: 10.1093/cid/ciy413

Table 3.

Management of Children Prior to Respiratory Syncytial Virus-Associated Death

Patient Outcome/Intervention (n = 79) No. (%)
Length of hospital admission, d, median (range) 25 (1–780)
ICU admission 74 (93.7)
Days in ICU, d, median (range) 10 (1–191)
In ICU for reason other than RSV 19 (24.1)
Received mechanical ventilation 65 (83.3)a
Received ECMO 7 (8.9)
Treated with palivizumab 7 (8.9)
Treated with RSV IVIG 1 (1.3)
Treated with IVIG 4 (5.1)
Treated with ribavirin 10 (12.7)

Data are presented as No. (%) unless otherwise indicated.

Abbreviations: ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit; IVIG, intravenous immunoglobulin; RSV, respiratory syncytial virus.

aDenominator of 78 (1 value not recorded).